Search research articles
Contact Us
Filters
Showing results (341-350 of 442) with videos related to
Page
of 45
Sort By:
NPJ Breast Cancer
|
October 2, 2024
Prognostic and therapeutic implications of tumor-restrictive type III collagen in the breast cancer microenvironment
Daniel C Stewart, Becky K Brisson, Bassil Dekky, et al.
JCO Precision Oncology
|
June 30, 2022
Genomic Landscape of Advanced Solid Tumors in Circulating Tumor DNA and Correlation With Tissue Sequencing: A Single Institution's Experience
Lorenzo Gerratana, Michael Movarek, Firas Wehbe, et al.
The Journal of Liquid Biopsy
|
June 16, 2025
International society of liquid biopsy (ISLB) perspective on minimal requirements for ctDNA testing in solid tumors
Nicola Fusco, Konstantinos Venetis, Francesco Pepe, et al.
Oncotarget
|
May 4, 2018
A pilot study of durvalumab and tremelimumab and immunogenomic dynamics in metastatic breast cancer
Cesar August Santa-Maria, Taigo Kato, Jae-Hyun Park, et al.
The Lancet. Oncology
|
March 8, 2016
Fulvestrant plus palbociclib versus fulvestrant plus placebo for treatment of hormone-receptor-positive, HER2-negative metastatic breast cancer that progressed on previous endocrine therapy (PALOMA-3): final analysis of the multicentre, double-blind, phase 3 randomised controlled trial
Massimo Cristofanilli, Nicholas C Turner, Igor Bondarenko, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 12, 2003
Gene expression profiles obtained from fine-needle aspirations of breast cancer reliably identify routine prognostic markers and reveal large-scale molecular differences between estrogen-negative and estrogen-positive tumors
Lajos Pusztai, Mark Ayers, James Stec, et al.
JCO Precision Oncology
|
June 17, 2021
Longitudinal Dynamics of Circulating Tumor Cells and Circulating Tumor DNA for Treatment Monitoring in Metastatic Breast Cancer
Lorenzo Gerratana, Andrew A Davis, Qiang Zhang, et al.
Breast Cancer Research : BCR
|
September 17, 2014
Circulating tumor cells as early predictors of metastatic spread in breast cancer patients with limited metastatic dissemination
Mario Giuliano, Antonio Giordano, Summer Jackson, et al.
International Journal of Radiation Oncology, Biology, Physics
|
June 23, 2009
Radiation Therapy Oncology Group translational research program stem cell symposium: incorporating stem cell hypotheses into clinical trials
Wendy A Woodward, Robert G Bristow, Michael F Clarke, et al.
Breast Cancer Research and Treatment
|
June 21, 2013
Inflammatory breast cancer (IBC): clues for targeted therapies
Sandra V Fernandez, Fredika M Robertson, Jianming Pei, et al.
Page
of 45
Search research articles
Search
Showing results (341-350 of 442) with videos related to
Sort By:
Page
of 45
NPJ Breast Cancer
|
October 2, 2024
Prognostic and therapeutic implications of tumor-restrictive type III collagen in the breast cancer microenvironment
Daniel C Stewart, Becky K Brisson, Bassil Dekky, et al.
JCO Precision Oncology
|
June 30, 2022
Genomic Landscape of Advanced Solid Tumors in Circulating Tumor DNA and Correlation With Tissue Sequencing: A Single Institution's Experience
Lorenzo Gerratana, Michael Movarek, Firas Wehbe, et al.
The Journal of Liquid Biopsy
|
June 16, 2025
International society of liquid biopsy (ISLB) perspective on minimal requirements for ctDNA testing in solid tumors
Nicola Fusco, Konstantinos Venetis, Francesco Pepe, et al.
Oncotarget
|
May 4, 2018
A pilot study of durvalumab and tremelimumab and immunogenomic dynamics in metastatic breast cancer
Cesar August Santa-Maria, Taigo Kato, Jae-Hyun Park, et al.
The Lancet. Oncology
|
March 8, 2016
Fulvestrant plus palbociclib versus fulvestrant plus placebo for treatment of hormone-receptor-positive, HER2-negative metastatic breast cancer that progressed on previous endocrine therapy (PALOMA-3): final analysis of the multicentre, double-blind, phase 3 randomised controlled trial
Massimo Cristofanilli, Nicholas C Turner, Igor Bondarenko, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 12, 2003
Gene expression profiles obtained from fine-needle aspirations of breast cancer reliably identify routine prognostic markers and reveal large-scale molecular differences between estrogen-negative and estrogen-positive tumors
Lajos Pusztai, Mark Ayers, James Stec, et al.
JCO Precision Oncology
|
June 17, 2021
Longitudinal Dynamics of Circulating Tumor Cells and Circulating Tumor DNA for Treatment Monitoring in Metastatic Breast Cancer
Lorenzo Gerratana, Andrew A Davis, Qiang Zhang, et al.
Breast Cancer Research : BCR
|
September 17, 2014
Circulating tumor cells as early predictors of metastatic spread in breast cancer patients with limited metastatic dissemination
Mario Giuliano, Antonio Giordano, Summer Jackson, et al.
International Journal of Radiation Oncology, Biology, Physics
|
June 23, 2009
Radiation Therapy Oncology Group translational research program stem cell symposium: incorporating stem cell hypotheses into clinical trials
Wendy A Woodward, Robert G Bristow, Michael F Clarke, et al.
Breast Cancer Research and Treatment
|
June 21, 2013
Inflammatory breast cancer (IBC): clues for targeted therapies
Sandra V Fernandez, Fredika M Robertson, Jianming Pei, et al.
Page
of 45